Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Standard BioTools Inc LAB

Standard BioTools Inc. develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines. The Company's segments include Proteomics and Genomics. The Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes its instruments... see more

NDAQ:LAB - Post Discussion

Standard BioTools Inc > fldm is up on possible sale exploration of one of its bus
View:
Post by Humanist on May 11, 2021 10:17am

fldm is up on possible sale exploration of one of its bus

** Activist investor Caligan Partners built an 11% stake in Fluidigm Corp, which makes a COVID-19 test, and may urge the company to conduct a strategic review and explore a sale of one of its business units, two sources said on Monday. (Compiled by Niket Nishant in Bengaluru)

Comment by personal on May 11, 2021 10:34am
I hope so, this has been a terrible investment, with all of the covid 19 tests being done, how can they still lose all that money.
Comment by Humanist on May 11, 2021 10:43am
i agree otally, because when i bought it around $8 i really had hopes that with all the testing going on in hte us especially, it would have jumped to about 14/15 which was the target price at some point, but not.. so cheers to hoping and best of luck
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities